Clinical Trials Directory

Trials / Completed

CompletedNCT00509418

Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis

Efficacy and Safety of Viusid, a Nutritional Supplement, in Patients With Nonalcoholic Steatohepatitis. A Randomized, Controlled and Open Label Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Catalysis SL · Industry
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to evaluate whether Viusid, a nutritional supplement, in combination with diet and exercise improve the histological results (steatosis, necro-inflammatory activity and fibrosis) in comparison with diet and exercise, during 24 weeks of treatment.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTViusidViusid, a nutritional supplement. Three oral sachets Daily 24 weeks
OTHERHypocaloric Diet with controlled exerciseModified ADA diet in combination with controlled exercise daily 24 weeks

Timeline

Start date
2007-02-01
Primary completion
2007-09-01
Completion
2007-09-01
First posted
2007-07-31
Last updated
2009-01-12

Locations

1 site across 1 country: Cuba

Source: ClinicalTrials.gov record NCT00509418. Inclusion in this directory is not an endorsement.

Efficacy and Safety of Viusid in Patients With Nonalcoholic Steatohepatitis (NCT00509418) · Clinical Trials Directory